Global Bovine Rotavirus Vaccine Market Growth 2026-2032
The global Bovine Rotavirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Bovine rotavirus is one of the main pathogens that cause viral diarrhea in calves. It has the characteristics of complex genotype, wide spread, high fatality rate, and interspecies transmission. Bovine rotavirus vaccine can effectively reduce viral diarrhea in calves.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Bovine Rotavirus Vaccine Industry Forecast? looks at past sales and reviews total world Bovine Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Bovine Rotavirus Vaccine sales for 2026 through 2032. With Bovine Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bovine Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Bovine Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bovine Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Bovine Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bovine Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bovine Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Bovine rotavirus is one of the main pathogens that cause viral diarrhea in calves. It has the characteristics of complex genotype, wide spread, high fatality rate, and interspecies transmission. Bovine rotavirus vaccine can effectively reduce viral diarrhea in calves.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Bovine Rotavirus Vaccine Industry Forecast? looks at past sales and reviews total world Bovine Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Bovine Rotavirus Vaccine sales for 2026 through 2032. With Bovine Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bovine Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Bovine Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bovine Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Bovine Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bovine Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bovine Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Attenuated Vaccine
- Inactivated Vaccine
- Calf
- Adult Cow
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- MSD Animal Health
- GSK
- Boehringer-Ingelheim
- Serum Institute of India
- Merck Animal Health
- Elanco Animal Health
- Pharmgal Bio
- Creative Biolabs
- Lanzhou Institute of Biological Products
- Weike Biotechnology
- What is the 10-year outlook for the global Bovine Rotavirus Vaccine market?
- What factors are driving Bovine Rotavirus Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Bovine Rotavirus Vaccine market opportunities vary by end market size?
- How does Bovine Rotavirus Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bovine Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Bovine Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Bovine Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Bovine Rotavirus Vaccine Segment by Type
2.2.1 Attenuated Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Bovine Rotavirus Vaccine Sales by Type
2.2.3.1 Global Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Bovine Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Bovine Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Bovine Rotavirus Vaccine Segment by Application
2.3.1 Calf
2.3.2 Adult Cow
2.3.3 Bovine Rotavirus Vaccine Sales by Application
2.3.3.1 Global Bovine Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Bovine Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Bovine Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Bovine Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Bovine Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Bovine Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Bovine Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Bovine Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Bovine Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Bovine Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Bovine Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bovine Rotavirus Vaccine Product Location Distribution
3.4.2 Players Bovine Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BOVINE ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Bovine Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Bovine Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Bovine Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Bovine Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Bovine Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Bovine Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Bovine Rotavirus Vaccine Sales Growth
4.4 APAC Bovine Rotavirus Vaccine Sales Growth
4.5 Europe Bovine Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Bovine Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Bovine Rotavirus Vaccine Sales by Country
5.1.1 Americas Bovine Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Bovine Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Bovine Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Bovine Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bovine Rotavirus Vaccine Sales by Region
6.1.1 APAC Bovine Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Bovine Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Bovine Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Bovine Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bovine Rotavirus Vaccine by Country
7.1.1 Europe Bovine Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Bovine Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Bovine Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Bovine Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bovine Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Bovine Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Bovine Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bovine Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Bovine Rotavirus Vaccine
10.4 Industry Chain Structure of Bovine Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bovine Rotavirus Vaccine Distributors
11.3 Bovine Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR BOVINE ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Bovine Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Bovine Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Bovine Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Bovine Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Bovine Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 MSD Animal Health
13.2.1 MSD Animal Health Company Information
13.2.2 MSD Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 MSD Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 MSD Animal Health Main Business Overview
13.2.5 MSD Animal Health Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 GSK Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Boehringer-Ingelheim
13.4.1 Boehringer-Ingelheim Company Information
13.4.2 Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Boehringer-Ingelheim Main Business Overview
13.4.5 Boehringer-Ingelheim Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Merck Animal Health
13.6.1 Merck Animal Health Company Information
13.6.2 Merck Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.6.3 Merck Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Merck Animal Health Main Business Overview
13.6.5 Merck Animal Health Latest Developments
13.7 Elanco Animal Health
13.7.1 Elanco Animal Health Company Information
13.7.2 Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.7.3 Elanco Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Elanco Animal Health Main Business Overview
13.7.5 Elanco Animal Health Latest Developments
13.8 Pharmgal Bio
13.8.1 Pharmgal Bio Company Information
13.8.2 Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.8.3 Pharmgal Bio Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pharmgal Bio Main Business Overview
13.8.5 Pharmgal Bio Latest Developments
13.9 Creative Biolabs
13.9.1 Creative Biolabs Company Information
13.9.2 Creative Biolabs Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.9.3 Creative Biolabs Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Creative Biolabs Main Business Overview
13.9.5 Creative Biolabs Latest Developments
13.10 Lanzhou Institute of Biological Products
13.10.1 Lanzhou Institute of Biological Products Company Information
13.10.2 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.10.3 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lanzhou Institute of Biological Products Main Business Overview
13.10.5 Lanzhou Institute of Biological Products Latest Developments
13.11 Weike Biotechnology
13.11.1 Weike Biotechnology Company Information
13.11.2 Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.11.3 Weike Biotechnology Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Weike Biotechnology Main Business Overview
13.11.5 Weike Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bovine Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Bovine Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Bovine Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Bovine Rotavirus Vaccine Segment by Type
2.2.1 Attenuated Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Bovine Rotavirus Vaccine Sales by Type
2.2.3.1 Global Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Bovine Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Bovine Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Bovine Rotavirus Vaccine Segment by Application
2.3.1 Calf
2.3.2 Adult Cow
2.3.3 Bovine Rotavirus Vaccine Sales by Application
2.3.3.1 Global Bovine Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Bovine Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Bovine Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Bovine Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Bovine Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Bovine Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Bovine Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Bovine Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Bovine Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Bovine Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Bovine Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bovine Rotavirus Vaccine Product Location Distribution
3.4.2 Players Bovine Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BOVINE ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Bovine Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Bovine Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Bovine Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Bovine Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Bovine Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Bovine Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Bovine Rotavirus Vaccine Sales Growth
4.4 APAC Bovine Rotavirus Vaccine Sales Growth
4.5 Europe Bovine Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Bovine Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Bovine Rotavirus Vaccine Sales by Country
5.1.1 Americas Bovine Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Bovine Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Bovine Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Bovine Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bovine Rotavirus Vaccine Sales by Region
6.1.1 APAC Bovine Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Bovine Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Bovine Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Bovine Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bovine Rotavirus Vaccine by Country
7.1.1 Europe Bovine Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Bovine Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Bovine Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Bovine Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bovine Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Bovine Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Bovine Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bovine Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Bovine Rotavirus Vaccine
10.4 Industry Chain Structure of Bovine Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bovine Rotavirus Vaccine Distributors
11.3 Bovine Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR BOVINE ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Bovine Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Bovine Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Bovine Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Bovine Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Bovine Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 MSD Animal Health
13.2.1 MSD Animal Health Company Information
13.2.2 MSD Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 MSD Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 MSD Animal Health Main Business Overview
13.2.5 MSD Animal Health Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 GSK Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Boehringer-Ingelheim
13.4.1 Boehringer-Ingelheim Company Information
13.4.2 Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Boehringer-Ingelheim Main Business Overview
13.4.5 Boehringer-Ingelheim Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Merck Animal Health
13.6.1 Merck Animal Health Company Information
13.6.2 Merck Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.6.3 Merck Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Merck Animal Health Main Business Overview
13.6.5 Merck Animal Health Latest Developments
13.7 Elanco Animal Health
13.7.1 Elanco Animal Health Company Information
13.7.2 Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.7.3 Elanco Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Elanco Animal Health Main Business Overview
13.7.5 Elanco Animal Health Latest Developments
13.8 Pharmgal Bio
13.8.1 Pharmgal Bio Company Information
13.8.2 Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.8.3 Pharmgal Bio Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pharmgal Bio Main Business Overview
13.8.5 Pharmgal Bio Latest Developments
13.9 Creative Biolabs
13.9.1 Creative Biolabs Company Information
13.9.2 Creative Biolabs Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.9.3 Creative Biolabs Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Creative Biolabs Main Business Overview
13.9.5 Creative Biolabs Latest Developments
13.10 Lanzhou Institute of Biological Products
13.10.1 Lanzhou Institute of Biological Products Company Information
13.10.2 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.10.3 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lanzhou Institute of Biological Products Main Business Overview
13.10.5 Lanzhou Institute of Biological Products Latest Developments
13.11 Weike Biotechnology
13.11.1 Weike Biotechnology Company Information
13.11.2 Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.11.3 Weike Biotechnology Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Weike Biotechnology Main Business Overview
13.11.5 Weike Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Bovine Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Bovine Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Attenuated Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 6. Global Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Bovine Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Bovine Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Bovine Rotavirus Vaccine Sale by Application (2021-2026) & (K Doses)
Table 11. Global Bovine Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Bovine Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Bovine Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Bovine Rotavirus Vaccine Sales by Company (2021-2026) & (K Doses)
Table 16. Global Bovine Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Bovine Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Bovine Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Bovine Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Bovine Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Bovine Rotavirus Vaccine Products Offered
Table 22. Bovine Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Bovine Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Doses)
Table 26. Global Bovine Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Bovine Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Bovine Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Bovine Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Doses)
Table 30. Global Bovine Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Bovine Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Bovine Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Bovine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 34. Americas Bovine Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Bovine Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 37. Americas Bovine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 38. APAC Bovine Rotavirus Vaccine Sales by Region (2021-2026) & (K Doses)
Table 39. APAC Bovine Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Bovine Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 42. APAC Bovine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 43. Europe Bovine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 44. Europe Bovine Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 46. Europe Bovine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 47. Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 48. Middle East & Africa Bovine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 50. Middle East & Africa Bovine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Bovine Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Bovine Rotavirus Vaccine
Table 53. Key Industry Trends of Bovine Rotavirus Vaccine
Table 54. Bovine Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Bovine Rotavirus Vaccine Distributors List
Table 57. Bovine Rotavirus Vaccine Customer List
Table 58. Global Bovine Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 59. Global Bovine Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Bovine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 61. Americas Bovine Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Bovine Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 63. APAC Bovine Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Bovine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 65. Europe Bovine Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Bovine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 67. Middle East & Africa Bovine Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Bovine Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Doses)
Table 69. Global Bovine Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Bovine Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Doses)
Table 71. Global Bovine Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Zoetis Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. MSD Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. MSD Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 79. MSD Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. MSD Animal Health Main Business
Table 81. MSD Animal Health Latest Developments
Table 82. GSK Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 84. GSK Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Boehringer-Ingelheim Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Boehringer-Ingelheim Main Business
Table 91. Boehringer-Ingelheim Latest Developments
Table 92. Serum Institute of India Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Serum Institute of India Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 94. Serum Institute of India Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Serum Institute of India Main Business
Table 96. Serum Institute of India Latest Developments
Table 97. Merck Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 99. Merck Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Merck Animal Health Main Business
Table 101. Merck Animal Health Latest Developments
Table 102. Elanco Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 104. Elanco Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Elanco Animal Health Main Business
Table 106. Elanco Animal Health Latest Developments
Table 107. Pharmgal Bio Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 109. Pharmgal Bio Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Pharmgal Bio Main Business
Table 111. Pharmgal Bio Latest Developments
Table 112. Creative Biolabs Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Creative Biolabs Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 114. Creative Biolabs Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Creative Biolabs Main Business
Table 116. Creative Biolabs Latest Developments
Table 117. Lanzhou Institute of Biological Products Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 119. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. Lanzhou Institute of Biological Products Main Business
Table 121. Lanzhou Institute of Biological Products Latest Developments
Table 122. Weike Biotechnology Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 124. Weike Biotechnology Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. Weike Biotechnology Main Business
Table 126. Weike Biotechnology Latest Developments
Table 1. Bovine Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Bovine Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Attenuated Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 6. Global Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Bovine Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Bovine Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Bovine Rotavirus Vaccine Sale by Application (2021-2026) & (K Doses)
Table 11. Global Bovine Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Bovine Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Bovine Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Bovine Rotavirus Vaccine Sales by Company (2021-2026) & (K Doses)
Table 16. Global Bovine Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Bovine Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Bovine Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Bovine Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Bovine Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Bovine Rotavirus Vaccine Products Offered
Table 22. Bovine Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Bovine Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Doses)
Table 26. Global Bovine Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Bovine Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Bovine Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Bovine Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Doses)
Table 30. Global Bovine Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Bovine Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Bovine Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Bovine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 34. Americas Bovine Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Bovine Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 37. Americas Bovine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 38. APAC Bovine Rotavirus Vaccine Sales by Region (2021-2026) & (K Doses)
Table 39. APAC Bovine Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Bovine Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 42. APAC Bovine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 43. Europe Bovine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 44. Europe Bovine Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 46. Europe Bovine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 47. Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2021-2026) & (K Doses)
Table 48. Middle East & Africa Bovine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Bovine Rotavirus Vaccine Sales by Type (2021-2026) & (K Doses)
Table 50. Middle East & Africa Bovine Rotavirus Vaccine Sales by Application (2021-2026) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Bovine Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Bovine Rotavirus Vaccine
Table 53. Key Industry Trends of Bovine Rotavirus Vaccine
Table 54. Bovine Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Bovine Rotavirus Vaccine Distributors List
Table 57. Bovine Rotavirus Vaccine Customer List
Table 58. Global Bovine Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 59. Global Bovine Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Bovine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 61. Americas Bovine Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Bovine Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Doses)
Table 63. APAC Bovine Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Bovine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 65. Europe Bovine Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Bovine Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Doses)
Table 67. Middle East & Africa Bovine Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Bovine Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Doses)
Table 69. Global Bovine Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Bovine Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Doses)
Table 71. Global Bovine Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Zoetis Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. MSD Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. MSD Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 79. MSD Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. MSD Animal Health Main Business
Table 81. MSD Animal Health Latest Developments
Table 82. GSK Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 84. GSK Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Boehringer-Ingelheim Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Boehringer-Ingelheim Main Business
Table 91. Boehringer-Ingelheim Latest Developments
Table 92. Serum Institute of India Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Serum Institute of India Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 94. Serum Institute of India Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Serum Institute of India Main Business
Table 96. Serum Institute of India Latest Developments
Table 97. Merck Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 99. Merck Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Merck Animal Health Main Business
Table 101. Merck Animal Health Latest Developments
Table 102. Elanco Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 104. Elanco Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Elanco Animal Health Main Business
Table 106. Elanco Animal Health Latest Developments
Table 107. Pharmgal Bio Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 109. Pharmgal Bio Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Pharmgal Bio Main Business
Table 111. Pharmgal Bio Latest Developments
Table 112. Creative Biolabs Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Creative Biolabs Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 114. Creative Biolabs Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. Creative Biolabs Main Business
Table 116. Creative Biolabs Latest Developments
Table 117. Lanzhou Institute of Biological Products Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 119. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 120. Lanzhou Institute of Biological Products Main Business
Table 121. Lanzhou Institute of Biological Products Latest Developments
Table 122. Weike Biotechnology Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 124. Weike Biotechnology Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 125. Weike Biotechnology Main Business
Table 126. Weike Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Bovine Rotavirus Vaccine
Figure 2. Bovine Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bovine Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Doses)
Figure 7. Global Bovine Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Bovine Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Bovine Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Bovine Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Attenuated Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Global Bovine Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Bovine Rotavirus Vaccine Consumed in Calf
Figure 16. Global Bovine Rotavirus Vaccine Market: Calf (2021-2026) & (K Doses)
Figure 17. Bovine Rotavirus Vaccine Consumed in Adult Cow
Figure 18. Global Bovine Rotavirus Vaccine Market: Adult Cow (2021-2026) & (K Doses)
Figure 19. Global Bovine Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 20. Global Bovine Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 21. Bovine Rotavirus Vaccine Sales by Company in 2026 (K Doses)
Figure 22. Global Bovine Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 23. Bovine Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Bovine Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Bovine Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Bovine Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Bovine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 28. Americas Bovine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Bovine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 30. APAC Bovine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Bovine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 32. Europe Bovine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Bovine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 34. Middle East & Africa Bovine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Bovine Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Bovine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Bovine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Bovine Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Bovine Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Bovine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Bovine Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Bovine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Bovine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Bovine Rotavirus Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Bovine Rotavirus Vaccine
Figure 73. Industry Chain Structure of Bovine Rotavirus Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Bovine Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Bovine Rotavirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Bovine Rotavirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Bovine Rotavirus Vaccine
Figure 2. Bovine Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bovine Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Doses)
Figure 7. Global Bovine Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Bovine Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Bovine Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Bovine Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Attenuated Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Global Bovine Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Bovine Rotavirus Vaccine Consumed in Calf
Figure 16. Global Bovine Rotavirus Vaccine Market: Calf (2021-2026) & (K Doses)
Figure 17. Bovine Rotavirus Vaccine Consumed in Adult Cow
Figure 18. Global Bovine Rotavirus Vaccine Market: Adult Cow (2021-2026) & (K Doses)
Figure 19. Global Bovine Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 20. Global Bovine Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 21. Bovine Rotavirus Vaccine Sales by Company in 2026 (K Doses)
Figure 22. Global Bovine Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 23. Bovine Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Bovine Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Bovine Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Bovine Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Bovine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 28. Americas Bovine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Bovine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 30. APAC Bovine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Bovine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 32. Europe Bovine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Bovine Rotavirus Vaccine Sales 2021-2026 (K Doses)
Figure 34. Middle East & Africa Bovine Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Bovine Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Bovine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Bovine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Bovine Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Bovine Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Bovine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Bovine Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Bovine Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Bovine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Bovine Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Bovine Rotavirus Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Bovine Rotavirus Vaccine
Figure 73. Industry Chain Structure of Bovine Rotavirus Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Bovine Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Bovine Rotavirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Bovine Rotavirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
